Henry Schein, Inc. (NASDAQ:HSIC) Stock Holdings Increased by State of Alaska Department of Revenue

State of Alaska Department of Revenue grew its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.8% in the first quarter, according to its most recent filing with the SEC. The firm owned 14,611 shares of the company’s stock after acquiring an additional 395 shares during the quarter. State of Alaska Department of Revenue’s holdings in Henry Schein were worth $1,000,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of HSIC. Rakuten Securities Inc. bought a new stake in shares of Henry Schein during the first quarter valued at about $34,000. Cardinal Capital Management increased its stake in Henry Schein by 3.3% during the 1st quarter. Cardinal Capital Management now owns 14,789 shares of the company’s stock valued at $1,013,000 after buying an additional 476 shares during the period. Exchange Traded Concepts LLC raised its position in shares of Henry Schein by 18.5% during the 1st quarter. Exchange Traded Concepts LLC now owns 10,264 shares of the company’s stock worth $703,000 after buying an additional 1,606 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its position in shares of Henry Schein by 0.5% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 53,134 shares of the company’s stock worth $3,639,000 after buying an additional 243 shares in the last quarter. Finally, Simon Quick Advisors LLC acquired a new stake in shares of Henry Schein in the 1st quarter worth approximately $225,000. Institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Wall Street Zen lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday, April 17th. Piper Sandler lowered their price target on Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 30th. Barrington Research dropped their price objective on Henry Schein from $90.00 to $86.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 6th. Finally, Wells Fargo & Company cut their price objective on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a report on Tuesday, May 6th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Henry Schein has an average rating of “Moderate Buy” and a consensus target price of $79.30.

Henry Schein Stock Performance

HSIC opened at $73.15 on Friday. The firm has a market cap of $8.90 billion, a PE ratio of 22.86, a P/E/G ratio of 2.35 and a beta of 0.86. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. The business has a fifty day simple moving average of $69.59 and a 200-day simple moving average of $71.24. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period in the previous year, the firm earned $1.10 earnings per share. Henry Schein’s revenue for the quarter was down .1% compared to the same quarter last year. As a group, equities analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.